We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-3.97%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$484B
AUM Growth
-$4.92B
Cap. Flow
+$23.6B
Cap. Flow %
4.87%
Top 10 Hldgs %
31.76%
Holding
15,382
New
1,669
Increased
5,510
Reduced
5,992
Closed
1,922

Sector Composition

Rank Sector Weight
1 Technology 2.72%
2 Healthcare 2.38%
3 Financials 2.3%
4 Consumer Discretionary 1.76%
5 Industrials 1.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MLSS icon
13151
PUT
Milestone Scientific
MLSS
$42.6M
$18K ﹤0.01%
12,100
+600
+5% +$876
MREO
13152
CALL
Mereo BioPharma
MREO
$47.3M
$18K ﹤0.01%
15,800
+300
+2% +$388
ONCY
13153
Oncolytics Biotech
ONCY
$95.8M
$18K ﹤0.01%
11,639
-83,696
-88% -$140K
PRPO icon
13154
Precipio
PRPO
$42.8M
$18K ﹤0.01%
+664
New +$18.4K
TRIB
13155
CALL
Trinity Biotech
TRIB
$8.39M
$18K ﹤0.01%
116
-11
-9% -$1.9K
SPPI
13156
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$18K ﹤0.01%
13,913
-502,006
-97% -$462K
ASPU
13157
CALL
DELISTED
ASPEN GROUP, INC.
ASPU
$18K ﹤0.01%
+11,200
New +$19.2K
RAAS
13158
CALL
DELISTED
Cloopen Group Holding Limited American Depositary Shares (each representing six (6) Class A Ordinary Shares)
RAAS
$18K ﹤0.01%
3,400
-20,267
-86% -$129K
HPX.WS
13159
DELISTED
HPX Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
HPX.WS
$18K ﹤0.01%
101,525
+1,511
+2% +$517
CFMS
13160
DELISTED
Conformis, Inc. Common Stock
CFMS
$18K ﹤0.01%
1,175
-9,739
-89% -$160K
TYME
13161
CALL
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
$18K ﹤0.01%
52,300
+17,900
+52% +$7.15K
BBLN.WS
13162
DELISTED
Babylon Holdings Limited Warrants, each exercisable for one Class A Ordinary Share
BBLN.WS
$18K ﹤0.01%
33,638
-1,211
-3% -$854
EVGN icon
13163
CALL
Evogene
EVGN
$7.26M
$17K ﹤0.01%
+1,320
New +$17.8K
MATH icon
13164
Metalpha Technology Holding
MATH
$42.1M
$17K ﹤0.01%
+16,181
New +$18.2K
STRM
13165
DELISTED
Streamline Health Solutions
STRM
$17K ﹤0.01%
+701
New +$15K
SVRA icon
13166
Savara
SVRA
$1.19B
$17K ﹤0.01%
+12,571
New +$15.1K
AMBR
13167
Amber International Holding Ltd
AMBR
$130M
$17K ﹤0.01%
+1,479
New +$42.3K
BEST
13168
CALL
DELISTED
BEST Inc. American Depositary Shares, each representing twenty (20) Class A Ordinary Shares
BEST
$17K ﹤0.01%
1,285
+270
+27% +$4.24K
AAU
13169
CALL
DELISTED
Almaden Minerals Ltd
AAU
$17K ﹤0.01%
46,500
+12,000
+35% +$3.86K
NEPT
13170
CALL
DELISTED
Neptune Wellness Solutions Inc. Ordinary Shares
NEPT
$17K ﹤0.01%
55
-56
-50% -$25.4K
ONCT
13171
CALL
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$17K ﹤0.01%
615
-1,295
-68% -$47.1K
SIOX
13172
CALL
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$17K ﹤0.01%
24,700
-12,400
-33% -$10.5K
CALC icon
13173
PUT
CalciMedica
CALC
$10.9M
$16K ﹤0.01%
936
-1,050
-53% -$20K
GOCO
13174
CALL
DELISTED
GoHealth
GOCO
$16K ﹤0.01%
900
-1,133
-56% -$35.3K
HEPA
13175
DELISTED
Hepion Pharmaceuticals
HEPA
$16K ﹤0.01%
12
-24
-67% -$26.5K

Similar funds

Citadel Advisors's Q1 2022 Portfolio in Review

As of Q1 2022, Citadel Advisors held 15,382 positions worth $484B, down 1% from $489B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Citadel Advisors deployed $23.6B of net new capital in Q1 2022, opening 1,669 new positions and adding to 5,510 existing holdings. Its largest new stake was iShares 20+ Year Treasury Bond ETF: 3,151,731 shares worth $416M.

By sector, the portfolio is most concentrated in Technology at 2.7% of assets, down from 3.1% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was NVIDIA, an estimated $518M trimmed.

  • Citadel Advisors's largest Q1 2022 buy was iShares 20+ Year Treasury Bond ETF: 3,151,731 shares worth $416M.
  • Citadel Advisors added most to State Street SPDR S&P 500 ETF Trust in Q1 2022, an estimated $555M increase.
  • Citadel Advisors's biggest Q1 2022 reduction was NVIDIA, cutting an estimated $518M.
  • Citadel Advisors fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $535M.
  • Citadel Advisors's ten largest holdings make up 32% of its $484B portfolio in Q1 2022.
  • Citadel Advisors opened 1,669 new positions and closed 1,922 in Q1 2022.
  • Citadel Advisors's portfolio value fell 1% quarter-over-quarter to $484B.

Based on Citadel Advisors's 13F filing for Q1 2022, filed 16 May 2022.